Titan America SA (“Titan America”), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, ...

The gross proceeds from the initial public offering are expected to be approximately $191 million, before deducting underwriting discounts and commissions and other offering expenses, and excluding ...

BofA Securities, Goldman Sachs & Co. LLC, Evercore ISI, Guggenheim Securities and Cantor acted as joint bookrunners for the offering.

Titan America's initial public offering was priced toward the low end of expectations, giving the U.S. arm of Belgian cement producer Titan Cement International an initial market value of about $2.95 ...

announced the pricing of its initial public offering (the "Offering") of 2,750,000 Class A ordinary shares at a public offering price of $4.10 per share. The Class A ordinary shares start trading ...

The initial public offering price is expected to be between $18.00 and $20.00 per share. Karman currently intends to use the net proceeds it receives from this offering, together with its existing ...

announced today the pricing of its initial public offering (the “Offering”) of 2,250,000 ordinary shares par value US$0.001 per share at a price of US$4.50 per share to the public, for a total ...

In addition, SailPoint intends to grant the underwriters a 30-day option to purchase an additional 7,500,000 shares of common stock at the initial public offering price, less underwriting ...

today announced the pricing of its upsized initial public offering of 10,588,233 shares of its common stock at a public offering price of $18.00 per share. In addition, Sionna has granted the ...

Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat ...